Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Physiological Reports|February 22, 2017
The role of natural killer T cells in a mouse model with spontaneous bile duct inflammationElisabeth Schrumpf, Xiaojun Jiang, Sebastian Zeissig, et al.
Transplantation Direct|August 9, 2016
Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in NorwayIna M Andersen, Bjarte Fosby, Kirsten M Boberg, et al.
Communications Biology|March 23, 2025
GPR35 prevents osmotic stress induced cell damageJoshua E Elias, Mekdes Debela, Gavin W Sewell, et al.
Hepatology (Baltimore, Md.)|September 30, 2015
Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus processCyriel Y Ponsioen, Roger W Chapman, Olivier Chazouillères, et al.
The American Journal of Pathology|December 18, 2017
Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary CholangitisGuido Carpino, Vincenzo Cardinale, Trine Folseraas, et al.
Gastroenterology|February 7, 2015
Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing CholangitisNatalie L Berntsen, Olav Klingenberg, Brian D Juran, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2016
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitisJohannes R Hov, Kirsten M Boberg, Eli Taraldsrud, et al.
World Journal of Gastroenterology|April 19, 2014
HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantationBjarte Fosby, Sigrid Næss, Johannes R Hov, et al.
Scandinavian Journal of Gastroenterology|February 15, 2021
Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitisAmandeep Kaur Dhillon, Christian Rupp, Annika Bergquist, et al.
Pageof 18